EUVIMEDEUVIMED entdecken
Crossref

Ifosfamide and vincristine in paediatric tumours. A phase II study

J de Kraker, Pa Voute

European Paediatric Haematology and Oncology · 1984

DOI: 10.3109/08880018409141708 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Paediatric Haematology and Oncology, 1984. Verfasst von J de Kraker und 1 weiteren Autor:innen. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 4 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In 25 patients previously treated extensively, ifosfamide with vincristine was used as last resource. Toxicity and antitumour effect were studied. All patients vomited. Haematuria and pancytopenia for more than one week were the main side effects. Thirteen patients responded. Six had a complete response. Four of these are now off therapy. Even although cyclophospha-mide was used in previous protocols, seven out of fourteen patients responded.

Zitieren

APA

Kraker, J. D., & Voute, P. (1984). Ifosfamide and vincristine in paediatric tumours. A phase II study. European Paediatric Haematology and Oncology. https://doi.org/10.3109/08880018409141708

Vancouver

Kraker JD, Voute P. Ifosfamide and vincristine in paediatric tumours. A phase II study. European Paediatric Haematology and Oncology. 1984. doi:10.3109/08880018409141708

BibTeX
@article{Kraker1984,
  author = {Kraker, J de and Voute, Pa},
  title = {Ifosfamide and vincristine in paediatric tumours. A phase II study},
  journal = {European Paediatric Haematology and Oncology},
  year = {1984},
  doi = {10.3109/08880018409141708}
}
Kostenlos starten →